NDC 70518-3158

Myrbetriq

Mirabegron

Myrbetriq is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Mirabegron.

• Product ID: 70518-3158_c72d36fe-33e6-2944-e053-2a95a90a9275
• NDC: 70518-3158
• Product Type: Human Prescription Drug
• Proprietary Name: Myrbetriq
• Generic Name: Mirabegron
• Dosage Form: Tablet, Film Coated, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-15
• Marketing Category: NDA /
• Application Number: NDA202611
• Labeler Name: REMEDYREPACK INC.
• Substance Name: MIRABEGRON
• Active Ingredient Strength: 25 mg/1
• Pharm Classes: beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70518-3158-0

30 POUCH in 1 BOX (70518-3158-0) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-3158-1)

• Marketing Start Date: 2021-07-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Myrbetriq" or generic name "Mirabegron"

NDC	Brand Name	Generic Name
0469-2601	Myrbetriq	mirabegron
0469-2602	Myrbetriq	mirabegron
0469-5020	Myrbetriq	mirabegron
55154-8712	Myrbetriq	mirabegron
55154-8713	Myrbetriq	mirabegron
70518-2435	Myrbetriq	mirabegron
70518-3158	Myrbetriq	mirabegron